ZNF714
gene geneOn this page
Summary
ZNF714 (zinc finger protein 714, HGNC:27124) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 714 (Q96N38). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 148206 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_182515
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27124 |
| Approved symbol | ZNF714 |
| Name | zinc finger protein 714 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000160352 |
| Ensembl biotype | protein_coding |
| Entrez | 148206 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 14 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000425625, ENST00000456283, ENST00000596053, ENST00000600535, ENST00000610902, ENST00000613286, ENST00000616183, ENST00000618008, ENST00000618422, ENST00000620627, ENST00000904346, ENST00000904347, ENST00000904348, ENST00000931179, ENST00000968193, ENST00000968194, ENST00000968195
RefSeq mRNA: 1 — MANE Select: NM_182515
NM_182515
CCDS: CCDS54239
Canonical transcript exons
ENST00000456283 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001177597 | 21083978 | 21084069 |
| ENSE00003669539 | 21098185 | 21098311 |
| ENSE00003719382 | 21116807 | 21125094 |
| ENSE00003735317 | 21098812 | 21098910 |
| ENSE00003752082 | 21082203 | 21082348 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 87.48.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.6498 / max 455.4540, expressed in 1583 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174880 | 10.7270 | 1518 |
| 174881 | 2.2236 | 768 |
| 174879 | 0.6992 | 375 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 87.48 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.22 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.89 | gold quality |
| ventricular zone | UBERON:0003053 | 85.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.23 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.24 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 81.24 | gold quality |
| endometrium | UBERON:0001295 | 79.20 | gold quality |
| corpus callosum | UBERON:0002336 | 79.07 | gold quality |
| thymus | UBERON:0002370 | 77.77 | gold quality |
| calcaneal tendon | UBERON:0003701 | 77.32 | gold quality |
| ovary | UBERON:0000992 | 77.17 | gold quality |
| bone marrow | UBERON:0002371 | 77.09 | gold quality |
| left ovary | UBERON:0002119 | 76.20 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.14 | gold quality |
| right ovary | UBERON:0002118 | 74.70 | gold quality |
| sural nerve | UBERON:0015488 | 74.69 | gold quality |
| cerebellum | UBERON:0002037 | 74.59 | gold quality |
| cerebellar cortex | UBERON:0002129 | 74.58 | gold quality |
| esophagus mucosa | UBERON:0002469 | 74.54 | gold quality |
| cerebellar vermis | UBERON:0004720 | 74.48 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.43 | gold quality |
| monocyte | CL:0000576 | 74.01 | gold quality |
| thyroid gland | UBERON:0002046 | 73.99 | gold quality |
| adrenal gland | UBERON:0002369 | 73.96 | gold quality |
| lymph node | UBERON:0000029 | 73.87 | gold quality |
| leukocyte | CL:0000738 | 73.77 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 73.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 73.54 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.78 |
| E-MTAB-6142 | no | 78.83 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
291 targeting ZNF714, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
Literature-anchored findings (GeneRIF, showing 1)
- ZNF714 Supports Pro-Oncogenic Features in Lung Cancer Cells. (PMID:37958512)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 714 — Q96N38 (reviewed: Q96N38)
All UniProt accessions (7): A0A087WU35, A0A087WV13, A0A087WX89, A0A087X1X4, A0A087X1Z8, I3L2D0, M0QY60
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96N38-1 | 1 | yes |
| Q96N38-2 | 2 | |
| Q96N38-3 | 3 |
RefSeq proteins (1): NP_872321* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13465
UniProt features (24 total): zinc finger region 14, splice variant 3, sequence variant 3, sequence conflict 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96N38-F1 | 68.35 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 69 (showing top):
chr19p12, FISCHER_DREAM_TARGETS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_DOWN_BY_2ND_EGF_PULSE, NFE2L2.V2, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ARID5B_TARGET_GENES, ASH1L_TARGET_GENES, PAX3_TARGET_GENES, PRKDC_TARGET_GENES, ZNF10_TARGET_GENES, ZNF2_TARGET_GENES, ZNF350_TARGET_GENES, ZNF711_TARGET_GENES, MIR12136
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF714 | ATAD3C | Q5T2N8 | 615 |
| ZNF714 | CYB5D2 | Q8WUJ1 | 462 |
| ZNF714 | ICA1L | Q8NDH6 | 450 |
| ZNF714 | CYP20A1 | Q6UW02 | 449 |
| ZNF714 | GK5 | Q6ZS86 | 447 |
| ZNF714 | ANAPC16 | Q96DE5 | 442 |
| ZNF714 | C17orf75 | Q9HAS0 | 427 |
| ZNF714 | DCAF10 | Q5QP82 | 426 |
| ZNF714 | ERICH1 | Q86X53 | 417 |
| ZNF714 | KRT38 | O76015 | 398 |
| ZNF714 | ARL11 | Q969Q4 | 398 |
| ZNF714 | SSH1 | Q8WYL5 | 398 |
| ZNF714 | PABIR3 | Q6P4D5 | 398 |
| ZNF714 | CIAO1 | O76071 | 380 |
| ZNF714 | FKBP14 | Q9NWM8 | 377 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF223 | CENPB | psi-mi:“MI:0914”(association) | 0.530 |
| PCBD1 | ZNF714 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LZTR1 | ZNF714 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF714 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| S100B | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL27A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF460 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF550 | MEIOC | psi-mi:“MI:0914”(association) | 0.350 |
| RPL15 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF48 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (20): ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-RNA), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS), ZNF714 (Positive Genetic), ZNF714 (Proximity Label-MS)
ESM2 similar proteins: A6NK75, A6NNF4, A6NP11, A8MTY0, A8MUV8, B4DXR9, C9JN71, O75346, O75373, O95780, P0CJ79, P0DKX0, P0DPD5, P17019, P17035, P35789, Q03923, Q03938, Q08AN1, Q14593, Q15928, Q3SXZ3, Q3ZCX4, Q5MCW4, Q5R9S5, Q5RER9, Q68DY1, Q6JLC9, Q6ZMV8, Q6ZN06, Q6ZN08, Q6ZNA1, Q76KX8, Q86T29, Q86V71, Q8IYN0, Q8N4W9, Q8N7M2, Q8NEM1, Q8TD23
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1028 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:21084039:G:GT | donor_gain | 1.0000 |
| 19:21116806:GCT:G | acceptor_gain | 1.0000 |
| 19:21116806:GCTAT:G | acceptor_gain | 1.0000 |
| 19:21082315:C:G | donor_gain | 0.9900 |
| 19:21082347:TGGT:T | donor_loss | 0.9900 |
| 19:21082349:GT:G | donor_loss | 0.9900 |
| 19:21098179:TTTCA:T | acceptor_loss | 0.9900 |
| 19:21098180:TTCA:T | acceptor_loss | 0.9900 |
| 19:21098181:TCA:T | acceptor_loss | 0.9900 |
| 19:21098182:CA:C | acceptor_loss | 0.9900 |
| 19:21098184:G:A | acceptor_loss | 0.9900 |
| 19:21098184:GGA:G | acceptor_gain | 0.9900 |
| 19:21098307:CTTGG:C | donor_loss | 0.9900 |
| 19:21098308:TTGGG:T | donor_loss | 0.9900 |
| 19:21098309:TGGGT:T | donor_loss | 0.9900 |
| 19:21098310:GG:G | donor_gain | 0.9900 |
| 19:21098311:GG:G | donor_gain | 0.9900 |
| 19:21098311:GGTG:G | donor_loss | 0.9900 |
| 19:21098312:G:GG | donor_gain | 0.9900 |
| 19:21098312:GTG:G | donor_loss | 0.9900 |
| 19:21098313:T:TC | donor_loss | 0.9900 |
| 19:21098314:G:GC | donor_loss | 0.9900 |
| 19:21116801:TTTCA:T | acceptor_loss | 0.9900 |
| 19:21116802:TTCA:T | acceptor_loss | 0.9900 |
| 19:21116804:CA:C | acceptor_loss | 0.9900 |
| 19:21116805:A:AG | acceptor_gain | 0.9900 |
| 19:21116805:A:G | acceptor_loss | 0.9900 |
| 19:21116806:G:GG | acceptor_gain | 0.9900 |
| 19:21116806:GCTA:G | acceptor_gain | 0.9900 |
| 19:21082335:G:GT | donor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000059832 (19:21114569 A>G), RS1000112467 (19:21099270 T>G), RS1000157519 (19:21090266 G>A,C,T), RS1000259438 (19:21114622 A>C,G), RS1000359138 (19:21101775 T>A), RS1000368200 (19:21107822 C>T), RS1000408806 (19:21089084 T>A,C), RS1000538965 (19:21120793 G>A,T), RS1000563822 (19:21083292 C>G), RS1000706944 (19:21097779 G>GGA), RS1000772753 (19:21096650 A>G), RS1000958696 (19:21097297 C>G), RS1001114066 (19:21114310 C>G), RS1001162850 (19:21088571 A>G), RS1001215232 (19:21088201 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 2 |
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| bisphenol A | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| methacrylaldehyde | decreases expression, increases abundance, affects cotreatment | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression, decreases reaction | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 1 |
| Allergens | increases expression | 1 |
| Vehicle Emissions | decreases expression, decreases reaction | 1 |
| Coal | increases abundance, decreases expression | 1 |
| Gallic Acid | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Ozone | affects cotreatment, decreases expression, increases abundance | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Particulate Matter | decreases expression, decreases reaction | 1 |
| Volatile Organic Compounds | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.